Zimmer Biomet

Health Care Health Care Equipment Warsaw, Indiana Last filing Feb 20, 2026 · FY2025

                    Revenue
                    FY2025
                
$8.2B
                    3y CAGR +5.9%
                    
                    P58
                    
                    +7.2%
                    
                    Net income
                    FY2025
                
$705.1M
                    Net margin +8.6%
                    
                    P38
                    
                    -22.0%
                    
                    Total assets
                    FY2025
                
$23.1B
                    ROA +3.1%
                    
                    P25
                    
                    +8.1%
                    
                    Operating cash flow
                    FY2025
                
$1.7B
                    FCF margin +17.9%
                    
                    P63
                    
                    +13.2%

19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 10 years

Total assets $23.1B

Total liabilities $10.4B

Shareholders equity $12.7B

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Assets
Cash and Cash Equivalents	7.2%	6.8%	5.6%	5.4%	7.0%	13.1%	7.7%	6.8%	6.7%	8.3%
Accounts Receivable	20.7%	19.3%	19.5%	19.9%	20.6%	23.7%	17.1%	16.1%	19.2%	20.9%
Inventory	27.8%	29.1%	32.3%	30.9%	35.1%	40.0%	29.9%	28.4%	26.7%	25.6%
Prepaid Expenses	6.5%	5.6%	5.0%	7.5%	4.1%	2.8%	4.5%	4.4%	5.3%	6.1%
Other Current Assets	13.4%	14.3%	15.6%	16.2%	15.6%	15.8%	12.3%	5.1%	5.0%	7.2%
Total Current Assets	62.2%	60.8%	62.3%	63.8%	71.6%	83.0%	59.2%	55.8%	57.9%	60.8%
Property,Plant and Equipment	26.8%	26.7%	27.9%	27.0%	29.5%	33.4%	26.0%	25.4%	26.1%	26.6%
Goodwill	120.8%	116.6%	119.3%	123.6%	130.6%	151.2%	120.3%	120.9%	136.7%	138.8%
Intangible Assets	57.3%	59.9%	65.7%	73.0%	92.3%	115.1%	90.9%	96.9%	107.0%	114.6%
Other Noncurrent Assets	13.4%	14.3%	15.6%	16.2%	15.6%	15.8%	12.3%	5.1%	5.0%	7.2%
Total Assets	280.5%	278.2%	290.7%	303.5%	343.6%	398.5%	308.7%	304.1%	332.7%	348.0%
Liabilities
Accounts Payable	3.7%	2.5%	5.6%	5.1%	5.1%	5.4%	5.0%	4.6%	4.2%	4.8%
Accrued Liabilities	5.8%	9.6%	8.5%	8.4%	10.8%	14.2%	9.7%	8.5%	10.2%	10.3%
Current Portion of Long Term Debt	7.1%	11.2%	12.2%	7.8%	23.5%	8.2%	18.8%	6.6%	15.7%	7.5%
Other Current Liabilities	20.6%	18.1%	20.1%	20.5%	21.2%	27.2%	17.7%	17.5%	16.7%	16.4%
Total Current Liabilities	31.4%	31.9%	38.6%	34.0%	50.8%	41.7%	43.1%	30.5%	38.7%	31.1%
Long Term Debt	84.2%	69.6%	65.8%	74.2%	80.0%	124.5%	84.2%	106.1%	114.3%	139.1%
Deferred Tax Liabilities	3.0%	4.6%	4.8%	6.8%	9.7%	12.9%	11.2%	17.8%	19.6%	47.5%
Other Noncurrent Liabilities	7.6%	9.7%	8.8%	9.1%	8.9%	10.7%	7.0%	4.4%	5.7%	12.2%
Total Liabilities	126.2%	115.8%	121.8%	130.2%	158.0%	199.4%	153.4%	162.0%	182.3%	221.9%
Equity
Preferred Stock	0.0%	0.0%	3.4%	0.0%	3.7%	0.0%	0.0%	0.0%	0.0%	0.0%
Common Stock	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
Additional Paid In Capital	123.7%	130.7%	133.2%	137.0%	136.4%	148.9%	111.7%	109.5%	109.1%	109.1%
Retained Earnings	141.1%	144.5%	140.4%	137.7%	150.8%	164.6%	130.6%	119.6%	128.4%	110.4%
Treasury Stock	108.0%	109.5%	102.3%	99.0%	98.4%	109.7%	84.2%	84.7%	86.1%	87.8%
Accumulated Other Comprehensive Income	-2.5%	-3.4%	-2.6%	-2.6%	-3.4%	-4.9%	-3.0%	-2.4%	-1.1%	-5.7%
Noncontrolling Interest	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	-0.0%	0.0%
Total Stockholders Equity	154.3%	162.4%	168.8%	173.2%	185.4%	199.0%	155.2%	142.1%	150.4%	126.1%
Total Liabilitiesand Equity	280.5%	278.2%	290.7%	303.5%	343.6%	398.5%	308.7%	304.1%	332.7%	348.0%

Income Statement

Revenue, expense, and profitability

17 accounts · 10 years

Revenue $8.2B

Operating income $1.1B

Net income $705.1M

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Expenses Cost of Revenue	30.3%	28.5%	28.2%	29.1%	28.7%	29.8%	28.2%	28.6%	27.3%	31.1%
Expenses Research and Development	5.6%	5.7%	6.2%	5.9%	6.4%	5.3%	5.6%	4.9%	4.7%	4.8%
Expenses Selling,General and Administrative	39.6%	38.2%	38.4%	39.8%	41.6%	44.3%	41.9%	42.6%	39.8%	38.4%
Expenses Depreciation and Amortization	13.3%	13.0%	12.9%	13.3%	13.7%	14.7%	12.6%	13.1%	13.6%	13.6%
Expenses Share Based Compensation	1.1%	1.3%	1.3%	1.5%	1.1%	1.2%	1.1%	0.8%	0.7%	0.7%
Expenses Operating Expenses	86.7%	83.3%	82.7%	90.0%	87.4%	98.6%	85.7%	99.6%	89.8%	89.3%
Other Income Expense Operating Income	13.3%	16.7%	17.3%	10.0%	12.6%	1.4%	14.3%	0.4%	10.2%	10.7%
Other Income Expense Other Income/expense	0.3%	-0.4%	-0.1%	-1.8%	0.2%	0.4%	-0.1%	-0.2%	-0.1%	-0.9%
Other Income Expense Income Before Tax	10.1%	13.5%	14.4%	5.8%	7.3%	-1.7%	11.3%	-3.4%	6.0%	5.2%
Income Tax Income Tax Expense	1.5%	1.7%	0.6%	1.6%	0.8%	-1.6%	-2.8%	1.4%	-17.3%	1.2%
net Income net Income	8.6%	11.8%	13.8%	3.3%	5.9%	-2.3%	14.2%	-4.8%	23.2%	4.0%
net Income Comprehensive Income	9.3%	10.8%	13.7%	3.2%	6.9%	-3.2%	13.5%	-5.6%	27.8%	2.6%
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	0.0%	-0.0%	0.0%	0.0%
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	0.0%	-0.0%	0.0%	0.0%
Earnings Per Share Weighted Average Shares Basic	2.4%	2.6%	2.8%	3.0%	3.1%	3.4%	2.6%	2.6%	2.6%	2.6%
Earnings Per Share Weighted Average Shares Diluted	2.4%	2.7%	2.8%	3.0%	3.1%	3.4%	2.6%	2.6%	2.6%	2.6%

Cash Flow Statement

Operating, investing, and financing flows

19 accounts · 10 years

Operating cash flow $1.7B

Investing cash flow $-2.0B

Financing cash flow $326.0M

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CashFlow
Operating Activities net Income	8.6%	11.8%	13.8%	3.3%	5.9%	-2.3%	14.2%	-4.8%	23.2%	4.0%
Operating Activities Depreciation and Amortization	13.3%	13.0%	12.9%	13.3%	13.7%	14.7%	12.6%	13.1%	5.8%	6.1%
Operating Activities Stock Based Compensation	1.1%	1.3%	1.3%	1.5%	1.1%	1.2%	1.1%	0.8%	0.7%	0.7%
Operating Activities Deferred Income Taxes	-1.1%	-0.6%	-1.3%	-0.9%	-1.5%	0.6%	-6.7%	0.2%	-22.8%	-2.0%
Operating Activities Changes In Operating Assets and Liabilities	-1.2%	-0.6%	3.3%	1.1%	0.1%	0.6%	1.6%	2.5%	1.5%	-1.0%
Operating Activities net Cash From Operating Activities	20.6%	19.5%	21.4%	—	22.0%	19.7%	19.9%	22.0%	20.3%	21.3%
Investing Activities Capital Expenditures	2.7%	2.7%	3.9%	2.7%	2.1%	1.8%	2.6%	2.1%	2.0%	2.4%
Investing Activities Other Investing Activities	0.1%	0.5%	-0.4%	0.5%	0.3%	0.3%	0.2%	0.4%	0.2%	0.0%
Investing Activities net Cash From Investing Activities	-24.0%	-11.6%	-10.5%	—	-7.4%	-10.0%	-9.1%	-5.3%	-6.5%	-22.1%
Financing Activities Proceeds From Debt	30.3%	18.7%	6.8%	8.6%	23.4%	24.4%	6.9%	9.4%	5.1%	9.8%
Financing Activities Repurchase of Common Stock	5.9%	11.3%	9.4%	1.8%	—	—	—	—	—	5.4%
Financing Activities Dividends Paid	2.3%	2.6%	2.7%	2.9%	2.9%	3.2%	2.5%	2.5%	2.5%	2.5%
Financing Activities Proceeds From Stock Issuance	0.5%	1.1%	1.4%	1.1%	1.8%	2.1%	2.0%	1.4%	1.9%	1.8%
Financing Activities Other Financing Activities	-0.2%	-0.3%	0.1%	-0.1%	2.1%	-0.1%	-0.1%	0.0%	-0.1%	-0.2%
Financing Activities net Cash From Financing Activities	4.0%	-6.3%	-10.3%	—	-19.1%	-6.9%	-9.8%	-16.4%	-15.5%	-9.7%
Cash Reconciliation Effect of Exchange Rate On Cash	0.2%	-0.2%	0.0%	-0.2%	-0.2%	0.2%	-0.0%	-0.1%	0.4%	-0.3%
Cash Reconciliation net Change In Cash	0.8%	1.4%	0.5%	-1.5%	-4.7%	3.0%	0.9%	0.2%	-1.4%	-10.8%
Cash Reconciliation Cash At Beginning of Period	7.2%	6.8%	5.6%	5.4%	7.0%	13.1%	7.7%	6.8%	6.7%	8.3%
Cash Reconciliation Cash At End of Period	7.2%	6.8%	5.6%	5.4%	7.0%	13.1%	7.7%	6.8%	6.7%	8.3%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years

Ratio	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Profitability
Gross margin	+69.7%	+71.5%	+71.8%	+70.9%	+71.3%	+70.2%	+71.8%	+71.4%	+72.7%	+68.9%
Operating margin	+13.3%	+16.7%	+17.3%	+10.0%	+12.6%	+1.4%	+14.3%	+0.4%	+10.2%	+10.7%
Net margin	+8.6%	+11.8%	+13.8%	+3.3%	+5.9%	-2.3%	+14.2%	-4.8%	+23.2%	+4.0%
FCF margin	+17.9%	+16.9%	+17.5%	—	+19.9%	+17.8%	+17.3%	+20.0%	+18.3%	+18.9%
Growth
Revenue CAGR (3y)	+5.9%	+4.0%	+6.5%	-4.6%	-4.9%	-7.7%	+1.3%	+9.8%	+18.6%	+18.4%
Returns
ROE	+5.6%	+7.2%	+8.2%	+1.9%	+3.2%	-1.1%	+9.1%	-3.4%	+15.5%	+3.2%
ROA	+3.1%	+4.2%	+4.8%	+1.1%	+1.7%	-0.6%	+4.6%	-1.6%	+7.0%	+1.1%
ROIC	+4.7%	+6.2%	+6.9%	+2.9%	+4.0%	+0.4%	+5.7%	+0.2%	+3.7%	+3.1%
Liquidity
Current ratio	1.98x	1.91x	1.61x	1.88x	1.41x	1.99x	1.37x	1.83x	1.50x	1.96x
Quick ratio	0.89x	0.82x	0.65x	0.75x	0.54x	0.88x	0.58x	0.75x	0.67x	0.94x
Leverage
D/E	0.82x	0.71x	0.72x	0.75x	0.85x	1.00x	0.99x	1.14x	1.21x	1.76x
Interest coverage	—	—	—	—	—	—	—	—	2.44x	2.29x
Efficiency
Asset turnover	0.36x	0.36x	0.34x	0.33x	0.29x	0.25x	0.32x	0.33x	0.30x	0.29x
Cash conversion cycle	+366d	+410d	+417d	+397d	+456d	+511d	+384d	+363d	+370d	+321d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Zimmer Biomet

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history